Search

everythinglearnresearchcommunity

for

Search:↓

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Fat cells help recruit healing cells and build skin structure during wound healing.

Skin fat cells help with skin balance, hair growth, and healing wounds.

Pectin biosynthesis is essential for the growth of cotton fibers and Arabidopsis root hairs.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

A very low-calorie ketogenic diet is effective for quick weight loss and improving health in obese patients, with careful management of side effects and maintenance.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

The intensive conventional diet with exercise led to better long-term weight loss and health improvements than the very low calorie diet in obese type 2 diabetics.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Minoxidil use in children may cause heart issues.